Archive for December 2025
Hogan Lovells advises Raselli Franco Group on the staged sale of its share capital to Kering
Regarding the agreement for the staged sale of its share capital to Kering S.A., Hogan Lovells has advised Raselli Franco Group, a family-run business known for its proficiency and quality in creating both high jewelry and fine jewelry items for luxury brands.
Read MoreHogan Lovells advises on the issuance of a €5 million minibond listed on Euronext Access Milano by Vezzani
Hogan Lovells served as deal counsel for Vezzani S.p.A.’s issuance and concurrent listing on Euronext Access Milan of a €5 million minibond with a 60-month term and a 12-month amortization period.
Read MoreGibson Dunn Advising Yarrow Bioscience on Merger with VYNE Therapeutics and Concurrent $200 Million Financings
Yarrow Bioscience is receiving advice from Gibson Dunn on its $200 million fundraising and merger with VYNE Therapeutics.
Read MoreGibson Dunn Advised Celanese Corporation on Concurrent $1.4 Billion Senior Notes Offering and $1.2 Billion Tender Offers
Celanese Corporation received advice from Gibson Dunn on its simultaneous $1.4 billion senior notes issuance and $1.2 billion tender offers.
Read MoreNorton Rose Fulbright advises the Council of the City of Gold Coast in Queensland, Australia, on landmark organics business acquisition
Norton Rose Fulbright provides historic organics company purchase advice to the Council of the City of Gold Coast on Queensland, Australia.
Read MoreBaker McKenzie Advises HSBC on Parnell Pharmaceutical’s AUD 110,000,000 Noble Pharma Acquisition Financing
Regarding a AUD 110,000,000 financing given to Parnell Pharmaceuticals Holdings Pty Ltd (“Parnell”), an affiliate of DW Healthcare Partners (“DWHP”), in connection with the purchase of Noble Pharma, LLC (“Noble Pharma”), Baker McKenzie has advised The Hong Kong and Shanghai Banking Corporation Limited as required lead arranger and bookrunner.
Read MoreHogan Lovells advises VIRTUS on its first data centre financing in Germany
Hogan Lovells, under the direction of Dr. Carla Luh and Stipe Bojanić, has provided financial advice to VIRTUS BERLIN1 GmbH and connected businesses regarding the financing of their first data center in Germany.
Read MoreNorton Rose Fulbright advises Wepa Hygieneprodukte GmbH on €500 million high-yield bond offering
Wepa Hygieneprodukte GmbH, a well-known family-owned tissue product manufacturer and supplier in Europe, has received advice from Norton Rose Fulbright regarding a successful €500 million issuance of 4.500% senior secured notes due in 2032.
Read MoreNorton Rose Fulbright advises AXA IM Alts on fundraising for Natural Capital and Impact investments strategy
AXA IM Alts, a global leader in alternative investments with over €188 billion in assets under management, has received advice from Norton Rose Fulbright on how to secure fresh fundraising commitments from several international development finance organizations for its Natural Capital and Impact investments strategy.
Read MoreDentons advises Pyrum Innovations on €13 million capital increase
Pyrum Innovations AG has received advice from Dentons for a €13 million capital increase in exchange for financial contributions and shareholder subscription rights.
Read More